LPL Financial
FBRX icon

LPL Financial’s Forte Biosciences FBRX Stock Holding History

LPL Financial’s Portfolio FBRX Stock Details FBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-396
Closed -$333K – 4356
2021
Q2 		$333K Hold
396
– – ﹤0.01% 3508
2021
Q1 		$339K Sell
396
-25
-6% -$20.5K ﹤0.01% 3380
2020
Q4 		$383K Buy
421
+5
+1% +$4.7K ﹤0.01% 2998
2020
Q3 		$504K Sell
416
-19
-4% -$12.6K ﹤0.01% 2450
2020
Q2 		$158K Buy
435
+258
+146% +$115K ﹤0.01% 3190
2020
Q1 		$81K Buy
177
+13
+8% +$5.08K ﹤0.01% 3026
2019
Q4 		$33K Hold
164
– – ﹤0.01% 3290
2019
Q3 		$41K Buy
164
+11
+7% +$16.7K ﹤0.01% 3217
2019
Q2 		$384K Buy
+153
New +$454K ﹤0.01% 2492

Other funds holding FBRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
OQS
Occudo Quantitative Strategies Fort Lauderdale, Florida $1.84B AUM 22.15% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

LPL Financial's FBRX Position: Q3 2021 in Review

LPL Financial sold out of Forte Biosciences (FBRX) in Q3 2021, closing a stake of 396 shares — an estimated $333K sold.

LPL Financial first reported a position in FBRX in Q2 2019 and held it in 9 quarters. The position peaked at $504K in Q3 2020. 57 funds tracked by Wall St. Rank hold FBRX as of Q3 2021.

  • LPL Financial reported no remaining Forte Biosciences position as of Q3 2021 after selling out during the quarter.
  • LPL Financial sold 396 Forte Biosciences shares in Q3 2021, an estimated $333K.
  • LPL Financial first reported a position in Forte Biosciences in Q2 2019 and held it in 9 quarters.
  • LPL Financial's Forte Biosciences position peaked at $504K in Q3 2020.
  • 57 funds tracked by Wall St. Rank held Forte Biosciences as of Q3 2021.

Based on LPL Financial's 13F filing for Q3 2021, filed 15 Nov 2021.